Listed

Design Therapeutics, Inc.

DSGNNasdaqCIK 1807120HealthcareFiscal year ends Dec 31

Reports and events: 76 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Design Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2022-12-2216:25 ETSC 13D/AOwnership report, active investor, amended0001193125-22-311061
2022-11-0316:16 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021885
2022-11-0316:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-021862
2022-08-0816:12 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-015533
2022-08-0816:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-015520
2022-06-1616:25 ET8-K5.07 Shareholder vote results0000950170-22-011751
2022-05-0916:14 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008500
2022-05-0916:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-008486
2022-04-2716:25 ETDEF 14AProxy statementPeriod 2022-06-150001193125-22-123683
2022-03-3116:23 ETSC 13DOwnership report, active investor0000935836-22-000298
2022-03-2216:36 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950170-22-004311
2022-03-1016:17 ET10-KAnnual reportPeriod 2021-12-310000950170-22-003369
2022-03-1016:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-003356
2021-11-0916:16 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003753
2021-11-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-003747
2021-08-2008:01 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-252071
2021-08-0917:18 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-042734
2021-08-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-042617
2021-08-0616:31 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-239304
2021-06-0716:26 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-031964
2021-05-1016:16 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-026062
2021-05-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-026050
2021-04-0915:38 ETSC 13DOwnership report, active investor0001193125-21-111505
2021-03-3016:44 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-100253
2021-03-2206:11 ETS-1/ARegistration statement, amended0001193125-21-088348
2021-03-0517:18 ETS-1Registration statement0001193125-21-071667

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 10:50 ET. Listed shows no prices and gives no investment advice.